NASDAQ$ACHC

Acadia Healthcare Company Inc. · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Acadia Healthcare's Q4 2021 financial results were announced, showing revenue growth and strategic investments.

Acadia Healthcare reported a revenue of $593.5 million for Q4 2021, a 10.7% increase in same facility revenue, and a net income of $70.3 million, or $0.77 per diluted share.

  • Revenue totaled $593.5 million.
  • Same facility revenue increased 10.7% compared to Q4 2020.
  • Net income attributable to Acadia Healthcare Company, Inc. totaled $70.3 million, or $0.77 per diluted share.
  • The company completed the acquisition of CenterPointe Behavioral Health System in Missouri.

Headline financials

Total Revenue

$593M

Previous: $541M+9.6%
EPS (adj)

$0.81

Previous: $1.13-28.3%
US Same-Facility Rev. Growth

10.7%

Previous: 7.6%+40.8%
US Same-Facility Patient Days Growth

2.7%

Previous: 3.6%-25.0%
US Same-Facility Rev/Day Growth

7.8%

Previous: 3.8%+105.3%
Capital Expenditures

$88.2M

Previous: $20.8M+324.4%
Free Cash Flow

$9.66M

Previous: $166M-94.2%
Net Income

$70.3M

Previous: -$783M+109.0%
Operating Income

$71.5M

Previous: $46.2M+55.0%
Gross Profit

$249M

Previous: $217M+14.7%
Cash & Equivalents

$134M

Previous: $379M-64.7%
Total Assets

$4.77B

Previous: $6.5B-26.6%
Stock-Based Comp

$12.5M

Previous: $6.25M+100.8%

Revenue & EPS history

Acadia Healthcare · Revenue · Quarterly

$593M

Q4 2021+9.6%vs Q4 2020
Beat estimate in 11 of 16 quarters(69%)
ActualEstimate

Forward guidance

Acadia provided financial guidance for 2022, projecting revenue between $2.55 to $2.60 billion and adjusted earnings per diluted share between $2.85 to $3.15.

Tailwinds

  • Revenue $2.55 to $2.60 billion
  • Adjusted EBITDA $575 to $610 million
  • Adjusted earnings per diluted share $2.85 to $3.15
  • Operating cash flows, including $39 million of CARES Act repayments $350 to $400 million
  • Primary objective for 2022 is to continue to extend our market reach with a goal to add 300 beds to existing facilities and pursue additional opportunities for de novo facilities, joint venture partnerships and acquisitions

Headwinds

  • Interest Expense $65 to $70 million
  • Tax rate 25% to 26%
  • Depreciation and amortization expense $120 to $130 million
  • Stock compensation expense Approximately $30 million
  • Expansion capital expenditures $290 to $340 million

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

+1.5%

Avg return

Earnings day

+1.4%

Avg return

5 days after

+2.5%

Avg return

30 days after

60%

38 / 63 earnings

Positive

+23.1%

Q3 2020

Best reaction

-26.9%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.5%+0.3%-16.0%
Q4 2025+21.4%+36.5%+33.4%
Q3 2025-5.5%-10.2%-25.2%
Q1 2025+4.2%+1.2%-14.4%
Q4 2024-25.5%-26.3%-25.2%
Q3 2024-17.3%-18.0%-21.3%
Q2 2024+10.0%+5.4%+21.6%
Q1 2024-9.8%-8.3%-6.8%
Q4 2023-2.4%-1.8%-7.3%
Q3 2023-1.7%+1.1%+0.5%
Q2 2023+7.8%+6.5%+2.9%
Q1 2023-1.3%-4.4%-6.0%
Q4 2022-9.6%-7.3%-12.1%
Q3 2022-3.4%-5.5%+7.2%
Q2 2022+3.6%+3.9%+4.8%
Q1 2022+8.0%+5.4%+6.4%
Q4 2021+6.5%+9.3%+15.3%
Q3 2021+10.5%+11.8%+3.0%
Q2 2021+3.1%+1.3%+8.0%
Q1 2021-1.1%+1.1%+4.4%
Q4 2020+1.5%+2.5%+6.0%
Q3 2020+23.1%+28.7%+49.1%
Q2 2020+2.3%+2.7%-0.1%
Q1 2020+16.7%+18.2%+26.7%
Q4 2019-5.9%+6.0%+100.5%
Q3 2019-3.5%-2.0%+2.5%
Q2 2019-3.3%-12.0%-19.6%
Q1 2019+0.0%+3.2%+1.4%
Q4 2018+15.9%+11.7%+11.7%
Q3 2018-12.8%-5.0%-26.0%
Q2 2018-10.6%-7.4%-8.0%
Q1 2018+9.0%+11.7%+13.0%
Q4 2017+8.5%+6.8%+8.4%
Q3 2017-26.9%-25.6%-30.7%
Q2 2017+7.6%+5.7%-7.5%
Q1 2017-3.1%+0.0%-2.4%
Q4 2016+5.4%+4.9%-1.7%
Q3 2016+3.1%+3.8%+5.9%
Q2 2016-1.3%-0.8%-4.8%
Q1 2016-0.8%
Q4 2015+5.7%
Q3 2015+9.4%
Q2 2015+3.4%
Q1 2015-2.9%
Q4 2014-0.4%
Q3 2014+11.2%
Q2 2014-2.1%
Q1 2014+0.4%
Q4 2013-2.8%
Q3 2013+9.0%
Q2 2013+8.2%
Q1 2013+2.9%
Q4 2009+2.3%
Q4 2012+0.1%
Q3 2012+2.3%
Q2 2012+7.5%
Q2 2011+4.4%
Q1 2012+6.5%
Q1 2011-1.0%
Q4 2011+3.3%
Q4 2010+0.1%
Q3 2011+0.1%
Q3 2010+0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro